Browse All

Current Filters

CLEAR FILTER x

TITLE

Serum Neurofilament Light Chain Levels are Elevated in Stiff Person Syndrome Spectrum Disorders

Author:Reyes, Maria   Dominguez Penuela, Susana   Hao, Samantha   Pardo-Villamizar, Carlos   Fitzgerald, Kathryn   Calabresi, Peter   Newsome, Scott   

Session Name:P1: Autoimmune Neurology: Stiff Person Syndrome and Paraneoplastic Neurologic Disorders  

Topic:Autoimmune Neurology  

Program Number:P1.008  

Author Institution:Hospital Simon Bolivar, Bogota, Colombia  Johns Hopkins University, Baltimore, MD  

Botulinum Toxin Has a Durable Treatment Effect in Stiff Person Syndrome

Author:Roman, Samantha   Taylor, Elena   Newsome, Scott   Moukheiber, Emile   

Session Name:P1: Autoimmune Neurology: Stiff Person Syndrome and Paraneoplastic Neurologic Disorders  

Topic:Autoimmune Neurology  

Program Number:P1.009  

Author Institution:Johns Hopkins Hospital, Baltimore, MD  

Severe Lumbar Stenosis Masquerading as Progression in Stiff Person Syndrome

Author:Miles, Ashley   Newsome, Scott   

Session Name:P1: Autoimmune Neurology: Stiff Person Syndrome and Paraneoplastic Neurologic Disorders  

Topic:Autoimmune Neurology  

Program Number:P1.012  

Author Institution:Johns Hopkins Hospital, Baltimore, MD  

Implementation of a Safety Program Initiative for Monitoring Infusion Disease Modifying Therapies for Multiple Sclerosis

Author:Roy, Shuvro   Haughton, Janel   Newsome, Scott   

Session Name:P10: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 3  

Topic:Multiple Sclerosis  

Program Number:P10.002  

Author Institution:University of Washington, Seattle, WA  Johns Hopkins Hospital, Baltimore, MD  

OCARINA I, Phase Ib Study: Dose Selection of Subcutaneous Ocrelizumab in Patients with Multiple Sclerosis

Author:Newsome, Scott   Goldstick, Lawrence   Townsend, Ben   Zecevic, Dusanka   Augustin, Aisha   Figueiredo, Catarina   Clinch, Susanne   Giacobino, Caroline   Bortolami, Oscar   Shen, Yun-An   Kletzl, Heidemarie   Bermel, Robert   

Session Name:P10: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 3  

Topic:Multiple Sclerosis  

Program Number:P10.003  

Author Institution:Johns Hopkins University School of Medicine, Baltimore, MD  University of Cincinnati, Cincinnati, OH  F. Hoffmann-La Roche Ltd., Basel, Switzerland  Roche Products Ltd. , Welwyn, United Kingdom  Genentech, San Fransisco, CA  Mellen Center for MS, Department of Neurology, Cleveland Clinic, Cleveland, OH